BANK VONTOBEL/CALL/MERCK & CO./140/0.1/21.06.24 Share Price

Warrant

DE000VD0NMX9

Market Closed - Deutsche Boerse AG 11:33:32 13/05/2024 pm IST
0.013 EUR -40.91% Intraday chart for BANK VONTOBEL/CALL/MERCK & CO./140/0.1/21.06.24
Current month-75.93%
1 month-82.43%
Date Price Change Volume
13/24/13 0.013 -40.91% 0
10/24/10 0.022 -8.33% 0
09/24/09 0.024 0.00% 0
08/24/08 0.024 +9.09% 0
07/24/07 0.022 +46.67% 0

Delayed Quote Deutsche Boerse AG

Last update May 13, 2024 at 11:33 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VD0NMX
ISINDE000VD0NMX9
Date issued 20/02/2024
Strike 140 $
Maturity 21/06/2024 (39 Days)
Parity 10 : 1
Emission price 0.15
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.215
Lowest since issue 0.012
Delta0.09x
Omega 39.26
Premium8.5x
Gearing452.19x
Moneyness 0.9235
Difference Strike 10.71 $
Difference Strike %+7.65%
Spread 0.019
Spread %52.78%
Intrinsic value 0.000000

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
129.3 USD
Average target price
141.6 USD
Spread / Average Target
+9.55%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW